Eterna Therapeutics Inc (ERNA) is expected to report for 4Q.
Graphite Bio Inc (GRPH) is expected to report for 4Q.
Groupon Inc (GRPN) is expected to report $-1.07 for 4Q.
Hibbett Inc (HIBB) is expected to report $2.54 for 4Q.
Jabil Inc (JBL) is expected to report $0.98 for 2Q.
KALA BIO Inc (KALA) is expected to report $-3.62 for 4Q.
KVH Industries (KVHI) is expected to report $-0.03 for 4Q.
Korro Bio Inc (KRRO) is expected to report for 4Q.
Legacy Housing Corp (LEGH) is expected to report $0.59 for 4Q.
Lendway Inc (LDWY) is expected to report for 4Q.
Lument Finance Trust Inc (LFT) is expected to report $0.10 for 4Q.
Neurogene Inc (NGNE) is expected to report $-0.94 for 4Q.
Oxford Square Capital Corp (OXSQ) is expected to report $0.70 for 4Q.
Perpetua Resources Corp (PPTA.T) is expected to report for 4Q.
Premium Brands Holdings (PBH.T,PRBZF) is expected to report $1.21 for 4Q.
ProPhase Labs (PRPH) is expected to report for 4Q.
Progressive Corp (PGR) is expected to report.
Quarterhill Inc (QTRH,QTRH.T) is expected to report for 4Q.
RLX Technology Inc - ADR (RLX) is expected to report $0.13 for 4Q.
Sonim Technologies Inc (SONM) is expected to report $0.01 for 4Q.
Summit Midstream Partners LP (SMLP) is expected to report $0.13 for 4Q.
Telos Corp (TLS) is expected to report $-0.18 for 4Q.
Townsquare Media Inc (TSQ) is expected to report $0.26 for 4Q.
Tredegar (TG) is expected to report for 4Q.
Viracta Therapeutics Inc (VIRX) is expected to report for 4Q.
Powered by Kantar Media and Dow Jones.
ANALYST RATINGS ACTIONS
Ashland Raised to Buy From Hold by Jefferies
Citigroup Inc Raised to Buy From Neutral by Goldman Sachs
Citigroup Raised to Buy From Neutral by Goldman Sachs
Cue Health Cut to Neutral From Buy by BTIG
Dick's Sporting Goods Raised to Buy From Hold by Williams Trading
FTC Solar Cut to Neutral From Buy by Roth MKM
Goldman Sachs Raised to Outperform From Neutral by Daiwa Capital
Haynes International Cut to Neutral From Buy by Northcoast Research
Immuneering Cut to Neutral From Buy by Guggenheim
Jack In The Box Raised to Outperform From Neutral by Wedbush
Maplebear Raised to Outperform From Market Perform by Bernstein
Marathon Oil Raised to Buy From Hold by Argus Research
NeuroPace Raised to Overweight From Equal-Weight by Wells Fargo
NewLake Capital Partners Raised to Buy From Neutral by Compass Point
Oportun Financial Cut to Hold From Buy by Jefferies
Oracle Raised to Buy From Hold by Argus Research
Palomar Holdings Raised to Buy From Hold by Jefferies
Paymentus Holdings Cut to Market Perform From Outperform by Raymond James
Raytheon Technologies Raised to Overweight From Equal-Weight by Wells Fargo
Rivian Automotive Raised to Overweight From Neutral by Piper Sandler
Solid Biosciences Raised to Overweight From Neutral by Piper Sandler
Spruce Biosciences Cut to Market Perform From Outperform by Leerink Partners
Spruce Biosciences Cut to Neutral From Buy by Guggenheim
Spruce Biosciences Cut to Neutral From Buy by HC Wainwright & Co.
Spruce Biosciences Cut to Neutral From Buy by Ladenburg Thalmann
Spruce Biosciences Cut to Sector Perform From Outperform by RBC Capital
Sterling Check Cut to Hold From Buy by Stifel
UGI Cut to Equal-Weight From Overweight by Wells Fargo
UiPath Raised to Overweight From Neutral by JP Morgan
Under Armour Cut to Hold From Buy by Williams Trading
Under Armour Cut to Neutral From Outperform by Exane BNP Paribas
Under Armour Cut to Underperform From In-Line by Evercore ISI Group
Utz Brands Raised to Buy From Neutral by B of A Securities
Williams-Sonoma Raised to Equal-Weight From Underweight by Morgan Stanley
Williams-Sonoma Raised to Neutral From Sell by Goldman Sachs
This article is a text version of a Wall Street Journal newsletter published earlier today.
(END) Dow Jones Newswires
03-15-24 0626ET
